 The Biological SCENE | Novartis Loses India Patent Fight The Biological SCENE ... protection for certain products in India. Last September, a court in Chennai allowed the compulsory licensing of the Bayer cancer drug Nexavar, and a court in Delhi declared that Roche could not obtain a patent for its lung cancer drug Tarceva (C ... |
